[go: up one dir, main page]

JPH08169801A - Oxygen addition device for organ preservation device - Google Patents

Oxygen addition device for organ preservation device

Info

Publication number
JPH08169801A
JPH08169801A JP6314572A JP31457294A JPH08169801A JP H08169801 A JPH08169801 A JP H08169801A JP 6314572 A JP6314572 A JP 6314572A JP 31457294 A JP31457294 A JP 31457294A JP H08169801 A JPH08169801 A JP H08169801A
Authority
JP
Japan
Prior art keywords
hollow fiber
oxygen
liquid
container
outlet
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP6314572A
Other languages
Japanese (ja)
Other versions
JP3603355B2 (en
Inventor
Akira Fujiwara
亮 藤原
Akio Shirasu
昭雄 白数
Hiroyuki Hattori
博行 服部
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nissho Corp
Original Assignee
Nissho Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nissho Corp filed Critical Nissho Corp
Priority to JP31457294A priority Critical patent/JP3603355B2/en
Publication of JPH08169801A publication Critical patent/JPH08169801A/en
Application granted granted Critical
Publication of JP3603355B2 publication Critical patent/JP3603355B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

(57)【要約】 【構成】 液体の入口・出口6、6’及び気体の入口・
出口5、5’を有する容器4内に半透性中空繊維2束を
詰め、容器内壁に液密に密接した固定部材3、3’で上
記半透性中空繊維2束両端を固定し、該半透性中空繊維
2の両端はそれぞれ開口状態に保たれたまま上記液体
(又は気体)の入口・出口5、5’、6、6’に連通さ
せてある臓器保存装置用酸素付加装置。 【効果】 灌流液への酸素の移行量が大きく、かつ、小
型の酸素付加装置で、摘出臓器をより長期にわたり、良
好な状態で保存でき、かつ移植後の生着率向上が期待で
きる。
(57) [Summary] [Structure] Liquid inlet / outlet 6, 6'and gas inlet /
Two bundles of semipermeable hollow fibers are packed in a container 4 having outlets 5 and 5 ', and both ends of the two bundles of semipermeable hollow fibers are fixed by fixing members 3 and 3'which are liquid tightly adhered to the inner wall of the container. An oxygen adding device for organ preservation device in which both ends of the semipermeable hollow fiber 2 are in communication with the inlets / outlets 5, 5 ′, 6, 6 ′ of the liquid (or gas) while being kept open. [Effect] With a large oxygen transfer amount to the perfusate and a small oxygenator, the excised organ can be preserved in a good condition for a longer period of time, and the survival rate after transplantation can be expected to improve.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】本発明は臓器保存装置用酸素付加
装置(oxygenator)に関する。さらに詳しく
は人体から摘出した臓器をドナーに移植するまでの間、
保存又は運搬に用いる臓器保存装置において、臓器への
還流液に酸素を十分供給する酸素付加装置に関する。
FIELD OF THE INVENTION The present invention relates to an oxygenator for an organ preservation device. More specifically, until transplanting the organ removed from the human body to the donor,
In an organ preservation device used for preservation or transportation, the present invention relates to an oxygen addition device that sufficiently supplies oxygen to reflux liquid to an organ.

【0002】[0002]

【従来の技術】摘出した臓器を保存するには単純冷却保
存法がある。これは単に容器内で臓器を冷凍或いは冷温
状態で保存するものだが、この方法によると臓器の保存
期間に限界がある。
2. Description of the Related Art A simple cold preservation method is available to preserve an excised organ. This is simply storing the organ in a container in a frozen or cold state, but this method limits the storage period of the organ.

【0003】このため低温還流保存法という方法が用い
られている。この装置の構造は灌流チェンバの他に酸素
付加装置・熱交換器・送液ポンプからなり、更に温度・
灌流圧・灌流量などのモニターや制御装置を有してい
る。
For this reason, a method called a low temperature reflux storage method is used. In addition to the perfusion chamber, the structure of this device consists of an oxygen addition device, a heat exchanger, a liquid feed pump, and
It has a monitor and control device for perfusion pressure and flow rate.

【0004】灌流チェンバに送られる灌流液の例を挙げ
ると、低温沈降法による血漿(CPP)・硫酸マグネシ
ウム・デキストロース・インスリン・ペニシリン・ハイ
ドロコーチゾンからなる液や血漿蛋白部分(PPF)・
アルブミン基調液がある。
As an example of the perfusate sent to the perfusion chamber, a liquid composed of plasma (CPP) / magnesium sulfate / dextrose / insulin / penicillin / hydrocortisone and a plasma protein portion (PPF) by a cryoprecipitation method.
There is an albumin base solution.

【0005】生体から摘出された臓器を長期間保存する
にあたり、臓器を構成する細胞組織に十分な酸素を供給
する必要があり、微生物の場合ならば、細孔のあいた部
材で保存液に空気を送り込み微小気泡の存在があっても
許されるが、臓器に酸素を供給する場合、臓器に気泡が
直接接することは好ましくない。その点に注意して灌流
液に酸素を溶解させねばならい。そのため気泡混入が発
生しない型での酸素付加装置がある。
When storing an organ excised from a living body for a long period of time, it is necessary to supply sufficient oxygen to the cell tissues that compose the organ. In the case of microorganisms, air is added to the preservation solution with a member having pores. The presence of microbubbles is also allowed, but when supplying oxygen to the organ, it is not preferable that the air bubbles come into direct contact with the organ. With that in mind, oxygen must be dissolved in the perfusate. Therefore, there is an oxygen addition device of a type in which air bubbles do not occur.

【0006】例えばハウジング内に内径が2〜3mm
で、外径が3〜3.5mm、長さが1〜2mのシリコン
チューブを入れ、チューブ内に灌流液を流し、チューブ
の外部に純度95%の酸素又は大気を入れて、灌流液に
酸素を溶解させていた。この場合シリコンが使用される
のは、それのガス透過性が高いからである。
For example, the inside diameter is 2-3 mm in the housing.
Then, put a silicon tube with an outer diameter of 3 to 3.5 mm and a length of 1 to 2 m, flow a perfusion solution into the tube, and put oxygen of 95% purity or the atmosphere into the outside of the tube to add oxygen to the perfusion solution. Had been dissolved. Silicon is used in this case because of its high gas permeability.

【0007】[0007]

【発明が解決しようとする課題】しかしながら、酸素の
移動量が大きく、かつ、小型の酸素付加装置とするには
シリコンチューブでは不十分であった。本発明はこの問
題点を解決するためになされたものである。
However, the silicon tube is not sufficient for a small-sized oxygen addition device in which a large amount of oxygen is transferred and which is small in size. The present invention has been made to solve this problem.

【0008】[0008]

【課題を解決するための手段】本発明は、液体の入口・
出口及び気体の入口・出口を有する容器内に半透性中空
繊維束を詰め、容器内壁に液密に密接した固定部材で上
記半透性中空繊維束両端を固定し、該半透性中空繊維の
両端はそれぞれ開口状態に保たれたまま上記液体(又は
気体)の入口・出口に連通させてあることを特徴とする
臓器保存装置用酸素付加装置を要旨とする。
SUMMARY OF THE INVENTION The present invention is directed to a liquid inlet
The semipermeable hollow fiber bundle is packed in a container having an outlet and a gas inlet / outlet, and both ends of the semipermeable hollow fiber bundle are fixed by fixing members that are liquid-tightly adhered to the inner wall of the container. An oxygen adding device for organ preservation device is characterized in that both ends thereof are communicated with an inlet / outlet of the liquid (or gas) while being kept open.

【0009】本発明において、容器(必要に応じてキャ
ップも用いられる)の材質はポリオレフィン・ポリカー
ボネート・ポリアクリレート・ポリアクリルニトリル・
ポリスチレン・ポリ塩化ビニル等が挙げられる。また、
容器の形態は筒状が製作上好ましい。この場合容器の両
端に流体の出入口が設けられる。しかし容器の形態を筒
状にこだわる必要もなく、例えば中空繊維束を容器内で
折り曲げて収納しても差し支えない。
In the present invention, the material of the container (a cap is also used if necessary) is polyolefin, polycarbonate, polyacrylate, polyacrylonitrile,
Examples include polystyrene and polyvinyl chloride. Also,
The shape of the container is preferably cylindrical for manufacturing. In this case, fluid inlets and outlets are provided at both ends of the container. However, it is not necessary to stick the shape of the container into a tubular shape, and for example, the hollow fiber bundle may be folded and stored in the container.

【0010】本発明において、半透性中空繊維は多孔性
膜が筒状になったもので、孔は微細であり、材質はポリ
アミド・ポリエステル・ポリビニルアルコール・ポリカ
ーボネート・ポリオレフィン・ポリスルホン・ポリアク
リレート等が使用される。半透性中空繊維の形態例は膜
の孔径は0.05〜0.1μm、内径が100〜100
0μm、膜厚が10〜50μmである。以上のような多
孔性膜を中空繊維状にして用いるのは、気−液の距離を
短縮させるのみならず、気−液接触面積(これを有効膜
面積という。)を大にできるからであり、また、装置の
製作がし易いことによる。
In the present invention, the semipermeable hollow fiber has a cylindrical porous membrane, fine pores, and is made of polyamide, polyester, polyvinyl alcohol, polycarbonate, polyolefin, polysulfone, polyacrylate, etc. used. The morphological example of the semipermeable hollow fiber has a membrane having a pore diameter of 0.05 to 0.1 μm and an inner diameter of 100 to 100.
The thickness is 0 μm and the film thickness is 10 to 50 μm. The reason why the porous membrane as described above is used in the form of a hollow fiber is that not only can the gas-liquid distance be shortened, but also the gas-liquid contact area (this is called the effective membrane area) can be increased. Also, it is easy to manufacture the device.

【0011】本発明において、容器内壁と固定部材を液
密に密接するのは気体と灌流液を分離しておくためであ
る。本発明において、固定部材の材料としてはエポキシ
樹脂・ポリウレタン・シリコン樹脂等が挙げられる。
In the present invention, the reason why the inner wall of the container and the fixing member are in liquid tight contact is to separate the gas and the perfusate. In the present invention, examples of the material of the fixing member include epoxy resin, polyurethane and silicone resin.

【0012】本発明の酸素付加装置を使用するに際して
は、中空繊維内に灌流液を通し中空繊維の外側に空気又
は酸素を流してよく、逆に中空繊維内に空気又は酸素を
通し中空繊維の外側に灌流液を流してもよい。いずれに
しても空気又は酸素を所定の圧力にしておくことが必要
である。
When the oxygenator of the present invention is used, a perfusate may be passed through the hollow fiber to allow air or oxygen to flow outside the hollow fiber, and conversely, air or oxygen may be passed through the hollow fiber to remove the hollow fiber. The perfusate may be flown outside. In any case, it is necessary to keep air or oxygen at a predetermined pressure.

【0013】[0013]

【作用】本発明の酸素付加装置を使用すれば、半透性膜
の孔から空気又は酸素が灌流液に移行するが、その孔径
が気泡が発生しないほどの細孔であるため気泡が灌流液
に混入するおそれがない。また膜が細い中空繊維の束で
あるので、有効膜面積が大となり空気又は酸素が灌流液
に効率よく移行でき、たとえ大気を用いたとしても灌流
液中の酸素の溶解量が飽和点に達することができる。
When the oxygenator of the present invention is used, air or oxygen is transferred from the pores of the semipermeable membrane to the perfusate, but since the pore size is such that bubbles do not occur, the bubbles are the perfusate. There is no danger of being mixed in. In addition, since the membrane is a bundle of thin hollow fibers, the effective membrane area becomes large, and air or oxygen can be efficiently transferred to the perfusate, and the dissolved amount of oxygen in the perfusate reaches the saturation point even if atmospheric air is used. be able to.

【0014】[0014]

【発明の効果】本発明は上記の構成であるので、灌流液
への酸素の移行量が大きく、かつ、小型の酸素付加装置
が得られる。その結果、本発明の酸素不可装置により摘
出臓器をより長期にわたり、良好な状態で保存でき、か
つ移植後の生着率向上が期待できる。
EFFECTS OF THE INVENTION Since the present invention has the above-mentioned structure, it is possible to obtain a small oxygen addition device in which the amount of oxygen transferred to the perfusate is large. As a result, it is expected that the removed organ can be preserved in a good condition for a longer period of time and the survival rate after transplantation can be improved by the oxygen impermeability device of the present invention.

【0015】[0015]

【実施例】以下、本発明を図面により説明する。図1は
本発明の臓器保存装置用酸素付加装置の一例を示し、そ
れを側面から眺めた断面図である。
DESCRIPTION OF THE PREFERRED EMBODIMENTS The present invention will be described below with reference to the drawings. FIG. 1 is a cross-sectional view showing an example of the oxygen adding device for an organ preservation device of the present invention, as viewed from the side.

【0016】図において、流体出入口6、6’を有する
キャップ7’、7が流体入口5、5’を有する外筒4の
両端に嵌合され、全てポリカーボネート製でできたハウ
ジング1を形成している。
In the drawing, caps 7 ', 7 having fluid inlets, outlets 6, 6'are fitted on both ends of an outer cylinder 4 having fluid inlets 5, 5'to form a housing 1 made entirely of polycarbonate. There is.

【0017】外筒4内に半透性中空繊維2が外筒の長手
方向と平行の位置で詰められてある。外筒4内で該繊維
2の両端をポリウレタンの固定部材3、3’で固定して
ある。なお、固定部材3、3’は外筒4の内壁に密接し
ている。中空繊維2の各フィラメントの先端は開口状態
に保たれ流体出入口6、6’に連通させてある。
Semipermeable hollow fibers 2 are packed in an outer cylinder 4 at a position parallel to the longitudinal direction of the outer cylinder. Both ends of the fiber 2 are fixed in the outer cylinder 4 by fixing members 3, 3'of polyurethane. The fixing members 3 and 3 ′ are in close contact with the inner wall of the outer cylinder 4. The tips of the filaments of the hollow fiber 2 are kept open and communicate with the fluid inlets and outlets 6, 6 '.

【0018】灌流液に酸素を溶解するときは、流体入口
6から灌流液を流入させ、中空繊維2の内側を通り、流
体出口6’から取り出される。一方、流体入口5から空
気又は所定の圧力で酸素を送り込み、空気又は酸素は中
空繊維2の外側を通り、流体出口5’から取り出され
る。
When dissolving oxygen in the perfusate, the perfusate is introduced from the fluid inlet 6, passes through the inside of the hollow fiber 2, and is taken out from the fluid outlet 6 '. On the other hand, air or oxygen is fed from the fluid inlet 5 at a predetermined pressure, and the air or oxygen passes through the outside of the hollow fiber 2 and is taken out from the fluid outlet 5 ′.

【0019】本発明の効果をみるために以下の実験を行
った。外径200μm、膜厚15μmのアセテートの中
空糸の約7000本(有効膜面積0.7平方メートル)
の両端をハウジング内で固定し、1つのモジュールを作
製し、中空糸内に窒素置換によって脱酸素化した蒸留水
を通し、中空糸外に大気を流量0.6リットル/分で通
気、蒸留水の流量を20〜200ミリリットル/分とし
た場合、モジュール出口で蒸留水の酸素分圧は180m
mHg(飽和点)となり、十分な置換が可能となった。
The following experiments were conducted to see the effects of the present invention. Approximately 7,000 acetate hollow fibers with an outer diameter of 200 μm and a film thickness of 15 μm (effective membrane area: 0.7 square meters)
Both ends of are fixed in the housing to make one module, the distilled water deoxygenated by nitrogen substitution is passed through the hollow fiber, and the atmosphere is ventilated outside the hollow fiber at a flow rate of 0.6 l / min. When the flow rate is 20 to 200 ml / min, the oxygen partial pressure of distilled water at the module outlet is 180 m
It became mHg (saturation point), and sufficient substitution was possible.

【0020】また逆に中空糸内に大気を中空糸外に水を
流しても、ほぼ同じ結果であった。
On the contrary, the same result was obtained by flowing the air into the hollow fiber and flowing the water out of the hollow fiber.

【0021】一方、蒸留水をCPP・硫酸マグネシウム
・デキストロース・インスリン・ペニシリン・ハイドロ
コーチゾンからなる液に替えて上記実験を行っても同様
の結果が得られた。
On the other hand, similar results were obtained when the above experiment was carried out by replacing the distilled water with a liquid containing CPP, magnesium sulfate, dextrose, insulin, penicillin, and hydrocortisone.

【0022】比較のために、ハウジング内に内径が2m
mで、外径が3mm、長さが1.5mのシリコンチュー
ブを入れ、チューブ内に窒素置換によって脱酸素化した
蒸留水を通し、チューブの外部に大気を流量0.6リッ
トル/分で通気入れて、蒸留水の流量を20〜200ミ
リリットル/分とした場合、モジュール出口で蒸留水の
酸素分圧は140mmHgとなり、実施例よりも劣る結
果となった。
For comparison, the inner diameter is 2 m in the housing.
m, an outer diameter of 3 mm, and a length of 1.5 m are put into the tube, distilled water deoxygenated by nitrogen substitution is passed through the tube, and the atmosphere is vented to the outside of the tube at a flow rate of 0.6 l / min. When the flow rate of distilled water was 20 to 200 ml / min after the addition, the oxygen partial pressure of distilled water at the module outlet was 140 mmHg, which was inferior to that of the example.

【0023】更にまた、マウス摘出肝をPPF系の灌流
液で保存した結果、上記シリコンの酸素付加装置で通気
したとき保存できた期間は3〜4日であったが、上記本
発明による酸素付加装置で通気したとき1週間以上の保
存が可能となった。
Furthermore, as a result of storing the liver of the mouse isolated with a PPF-based perfusate, it was possible to store it for 3 to 4 days when aerated with the above-mentioned oxygenator for silicon. When aerated with the device, it was possible to store for more than one week.

【図面の簡単な説明】[Brief description of drawings]

【図1】本発明の臓器保存装置用酸素付加装置の一例を
示し、それを側面から眺めた断面図。
FIG. 1 is a cross-sectional view showing an example of an oxygen adding device for an organ preservation device of the present invention, as viewed from the side.

【符号の説明】[Explanation of symbols]

1 ハウジング 2 中空繊維 3 固定部材 4 外筒 5 流体出入口 6 流体出入口 7 キャップ 1 Housing 2 Hollow Fiber 3 Fixing Member 4 Outer Cylinder 5 Fluid Port 6 Fluid Port 7 Cap

Claims (2)

【特許請求の範囲】[Claims] 【請求項1】 液体の入口・出口及び気体の入口・出口
を有する容器内に半透性中空繊維束を詰め、容器内壁に
液密に密接した固定部材で上記半透性中空繊維束両端を
固定し、該半透性中空繊維の両端はそれぞれ開口状態に
保たれたまま上記液体の入口・出口に連通させてあるこ
とを特徴とする臓器保存装置用酸素付加装置。
1. A semipermeable hollow fiber bundle is packed in a container having a liquid inlet / outlet and a gas inlet / outlet, and both ends of the semipermeable hollow fiber bundle are fixed to a container inner wall in liquid tight contact with each other. An oxygen adding device for organ preservation device, characterized in that the semipermeable hollow fiber is fixed and communicated with the inlet and the outlet of the liquid while keeping both ends open.
【請求項2】 液体の入口・出口及び気体の入口・出口
を有する容器内に半透性中空繊維束を詰め、容器内壁に
液密に密接した固定部材で上記半透性中空繊維束両端を
固定し、該半透性中空繊維の両端はそれぞれ開口状態に
保たれたまま上記気体の入口・出口に連通させてあるこ
とを特徴とする臓器保存装置用酸素付加装置。
2. A semipermeable hollow fiber bundle is packed in a container having a liquid inlet / outlet and a gas inlet / outlet, and both ends of the semipermeable hollow fiber bundle are fixed to a container inner wall in a liquid-tight manner by a fixing member. An oxygen adding device for organ preservation device, characterized in that both ends of the semipermeable hollow fiber are fixed and communicated with the gas inlet / outlet while being kept open.
JP31457294A 1994-12-19 1994-12-19 Oxygenator for organ preservation device Expired - Fee Related JP3603355B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP31457294A JP3603355B2 (en) 1994-12-19 1994-12-19 Oxygenator for organ preservation device

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP31457294A JP3603355B2 (en) 1994-12-19 1994-12-19 Oxygenator for organ preservation device

Publications (2)

Publication Number Publication Date
JPH08169801A true JPH08169801A (en) 1996-07-02
JP3603355B2 JP3603355B2 (en) 2004-12-22

Family

ID=18054903

Family Applications (1)

Application Number Title Priority Date Filing Date
JP31457294A Expired - Fee Related JP3603355B2 (en) 1994-12-19 1994-12-19 Oxygenator for organ preservation device

Country Status (1)

Country Link
JP (1) JP3603355B2 (en)

Cited By (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1435777A4 (en) * 2001-09-14 2004-11-24 Organ Transp Systems Inc Organ preservation apparatus and methods
US8685709B2 (en) 2009-09-25 2014-04-01 Board Of Regents Of The University Of Texas System Fluidics based pulsatile perfusion preservation device and method
US8835158B2 (en) 2011-03-15 2014-09-16 Paragonix Technologics, Inc. Apparatus for oxygenation and perfusion of tissue for organ preservation
US9155297B2 (en) 2012-08-10 2015-10-13 Paragonix Technologies, Inc. Methods and systems for assessing the suitability of an organ for transplant
US9426979B2 (en) 2011-03-15 2016-08-30 Paragonix Technologies, Inc. Apparatus for oxygenation and perfusion of tissue for organ preservation
US9867368B2 (en) 2011-03-15 2018-01-16 Paragonix Technologies, Inc. System for hypothermic transport of samples
US9936689B2 (en) 2011-03-15 2018-04-10 Paragonix Technologies, Inc. Methods and devices for preserving tissues
USD819223S1 (en) 2014-10-10 2018-05-29 Paragonix Technologies, Inc. Transporter for a tissue transport system
US11089775B2 (en) 2011-03-15 2021-08-17 Paragonix Technologies, Inc. System for hypothermic transport of samples
US11166452B2 (en) 2017-06-07 2021-11-09 Paragonix Technologies, Inc. Apparatus for tissue transport and preservation
US11178866B2 (en) 2011-03-15 2021-11-23 Paragonix Technologies, Inc. System for hypothermic transport of samples
EP3794943A4 (en) * 2018-05-31 2022-05-11 Aichi Medical University BIOMATERIAL PRESERVATION COMPOSITION, BIOMATERIAL PRESERVATION METHOD, BIOMATERIAL PRODUCTION METHOD, TRANSPLANTATION MATERIAL AND TRANSPLANTATION METHOD
US11632951B2 (en) 2020-01-31 2023-04-25 Paragonix Technologies, Inc. Apparatus for tissue transport and preservation
USD1031028S1 (en) 2022-09-08 2024-06-11 Paragonix Technologies, Inc. Tissue suspension adaptor
US12035708B2 (en) 2011-03-15 2024-07-16 Paragonix Technologies, Inc. System for hypothermic transport of samples
US12096765B1 (en) 2011-03-15 2024-09-24 Paragonix Technologies, Inc. System for hypothermic transport of samples
US12245585B2 (en) 2019-06-11 2025-03-11 Paragonix Technonogies, Inc. Organ transport container with antiviral therapy
US12357533B2 (en) 2023-08-25 2025-07-15 Paragonix Technologies, Inc. Systems and methods for maintaining organ pressure
USD1087382S1 (en) 2025-01-30 2025-08-05 Paragonix Technologies, Inc. Device for transporting a biological sample
US12410408B2 (en) 2024-02-02 2025-09-09 Paragonix Technologies, Inc. Method for hypothermic transport of biological samples
US12543729B2 (en) 2025-06-11 2026-02-10 Paragonix Technologies, Inc. System for hypothermic transport of samples

Citations (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5528940A (en) * 1978-08-22 1980-02-29 Senko Ika Kogyo Kk Perfusion device for organ
JPS5944267A (en) * 1982-09-02 1984-03-12 テルモ株式会社 Hollow yarn type artificial lung
JPS6120559A (en) * 1984-07-04 1986-01-29 テルモ株式会社 Hollow yarn type artificial lung
JPS61119272A (en) * 1984-11-14 1986-06-06 帝人株式会社 Capillary lung artificial lung
JPS61218501A (en) * 1985-03-22 1986-09-29 Senko Ika Kogyo Kk Apparatus for internal organ perfusion
JPS62106770A (en) * 1985-07-16 1987-05-18 テルモ株式会社 Hollow yarn membrane for artificial lang, its production andartificial lang using said hollow yarn membrane
JPS63270601A (en) * 1987-04-30 1988-11-08 Olympus Optical Co Ltd Apparatus for storing internal organs
JPS6440401A (en) * 1987-08-07 1989-02-10 Olympus Optical Co Device for preserving organ
JPH01104271A (en) * 1987-07-11 1989-04-21 Dainippon Ink & Chem Inc Membrane type oxygenator
JPH0129578B2 (en) * 1985-10-04 1989-06-12 Terumo Corp
JPH05228208A (en) * 1992-02-25 1993-09-07 Toyobo Co Ltd Cellulose acetate base blood purifying hollow thread membrane and its manufacture

Patent Citations (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5528940A (en) * 1978-08-22 1980-02-29 Senko Ika Kogyo Kk Perfusion device for organ
JPS5944267A (en) * 1982-09-02 1984-03-12 テルモ株式会社 Hollow yarn type artificial lung
JPS6120559A (en) * 1984-07-04 1986-01-29 テルモ株式会社 Hollow yarn type artificial lung
JPS61119272A (en) * 1984-11-14 1986-06-06 帝人株式会社 Capillary lung artificial lung
JPS61218501A (en) * 1985-03-22 1986-09-29 Senko Ika Kogyo Kk Apparatus for internal organ perfusion
JPS62106770A (en) * 1985-07-16 1987-05-18 テルモ株式会社 Hollow yarn membrane for artificial lang, its production andartificial lang using said hollow yarn membrane
JPH0129578B2 (en) * 1985-10-04 1989-06-12 Terumo Corp
JPS63270601A (en) * 1987-04-30 1988-11-08 Olympus Optical Co Ltd Apparatus for storing internal organs
JPH01104271A (en) * 1987-07-11 1989-04-21 Dainippon Ink & Chem Inc Membrane type oxygenator
JPS6440401A (en) * 1987-08-07 1989-02-10 Olympus Optical Co Device for preserving organ
JPH05228208A (en) * 1992-02-25 1993-09-07 Toyobo Co Ltd Cellulose acetate base blood purifying hollow thread membrane and its manufacture

Cited By (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1435777A4 (en) * 2001-09-14 2004-11-24 Organ Transp Systems Inc Organ preservation apparatus and methods
US7176015B2 (en) 2001-09-14 2007-02-13 Organ Transport Systems, Inc. Organ preservation apparatus and methods
US8685709B2 (en) 2009-09-25 2014-04-01 Board Of Regents Of The University Of Texas System Fluidics based pulsatile perfusion preservation device and method
US12245586B2 (en) 2011-03-15 2025-03-11 Paragonix Technologies, Inc. System for hypothermic transport of samples
US12035708B2 (en) 2011-03-15 2024-07-16 Paragonix Technologies, Inc. System for hypothermic transport of samples
US9426979B2 (en) 2011-03-15 2016-08-30 Paragonix Technologies, Inc. Apparatus for oxygenation and perfusion of tissue for organ preservation
US9867368B2 (en) 2011-03-15 2018-01-16 Paragonix Technologies, Inc. System for hypothermic transport of samples
US9936689B2 (en) 2011-03-15 2018-04-10 Paragonix Technologies, Inc. Methods and devices for preserving tissues
US8835158B2 (en) 2011-03-15 2014-09-16 Paragonix Technologics, Inc. Apparatus for oxygenation and perfusion of tissue for organ preservation
US11089775B2 (en) 2011-03-15 2021-08-17 Paragonix Technologies, Inc. System for hypothermic transport of samples
US11178866B2 (en) 2011-03-15 2021-11-23 Paragonix Technologies, Inc. System for hypothermic transport of samples
US12052985B2 (en) 2011-03-15 2024-08-06 Paragonix Technologies, Inc. System for hypothermic transport of samples
US12369576B2 (en) 2011-03-15 2025-07-29 Paragonix Technologies, Inc. System for hypothermic transport of samples
US12342810B2 (en) 2011-03-15 2025-07-01 Paragonix Technologies, Inc. System for hypothermic transport of samples
US12096765B1 (en) 2011-03-15 2024-09-24 Paragonix Technologies, Inc. System for hypothermic transport of samples
US12279610B2 (en) 2011-03-15 2025-04-22 Paragonix Technonogies, Inc. System for hypothermic transport of samples
US12121023B1 (en) 2011-03-15 2024-10-22 Paragonix Technologies, Inc. System for hypothermic transport of samples
US9155297B2 (en) 2012-08-10 2015-10-13 Paragonix Technologies, Inc. Methods and systems for assessing the suitability of an organ for transplant
USD819223S1 (en) 2014-10-10 2018-05-29 Paragonix Technologies, Inc. Transporter for a tissue transport system
US11659834B2 (en) 2017-06-07 2023-05-30 Paragonix Technologies, Inc. Apparatus for tissue transport and preservation
US11166452B2 (en) 2017-06-07 2021-11-09 Paragonix Technologies, Inc. Apparatus for tissue transport and preservation
US12082574B2 (en) 2018-05-31 2024-09-10 Aichi Medical University Biomaterial preservation composition having a microbubble with oxygen gas in liquid, method for preserving biomaterial in the biomaterial preservation composition, method for preserving biomaterial in the biomaterial preservation composition, method for producing biomaterial using the biomaterial preservation composition, transplantation material using the biomaterial preservation composition and method of transplantation using the biomaterial preservation composition
EP3794943A4 (en) * 2018-05-31 2022-05-11 Aichi Medical University BIOMATERIAL PRESERVATION COMPOSITION, BIOMATERIAL PRESERVATION METHOD, BIOMATERIAL PRODUCTION METHOD, TRANSPLANTATION MATERIAL AND TRANSPLANTATION METHOD
US12245585B2 (en) 2019-06-11 2025-03-11 Paragonix Technonogies, Inc. Organ transport container with antiviral therapy
US11632951B2 (en) 2020-01-31 2023-04-25 Paragonix Technologies, Inc. Apparatus for tissue transport and preservation
US12070029B2 (en) 2020-01-31 2024-08-27 Paragonix Technologies, Inc. Apparatus for tissue transport and preservation
US12310357B2 (en) 2020-01-31 2025-05-27 Paragonix Technologies, Inc. Apparatus for tissue transport and preservation
US12161110B2 (en) 2020-01-31 2024-12-10 Paragonix Technologies, Inc. Apparatus for tissue transport and preservation
US12178206B2 (en) 2020-01-31 2024-12-31 Paragonix Technologies, Inc. Apparatus for tissue transport and preservation
USD1031028S1 (en) 2022-09-08 2024-06-11 Paragonix Technologies, Inc. Tissue suspension adaptor
US12357533B2 (en) 2023-08-25 2025-07-15 Paragonix Technologies, Inc. Systems and methods for maintaining organ pressure
US12485064B2 (en) 2023-08-25 2025-12-02 Paragonix Technologies, Inc. Systems and methods for measuring oxygen concentration for lung preservation
US12410408B2 (en) 2024-02-02 2025-09-09 Paragonix Technologies, Inc. Method for hypothermic transport of biological samples
USD1087382S1 (en) 2025-01-30 2025-08-05 Paragonix Technologies, Inc. Device for transporting a biological sample
US12543729B2 (en) 2025-06-11 2026-02-10 Paragonix Technologies, Inc. System for hypothermic transport of samples

Also Published As

Publication number Publication date
JP3603355B2 (en) 2004-12-22

Similar Documents

Publication Publication Date Title
JPH08169801A (en) Oxygen addition device for organ preservation device
US5356771A (en) Combined perfusion and oxygenation organ preservation apparatus
US5362622A (en) Combined perfusion and oxygenation apparatus
US8906688B2 (en) Cell expansion system and methods of use
US3843455A (en) Apparatus and technique for preservation of isolated organs through perfusion
US20060121439A1 (en) Organ preservation and transportation apparatus and method
US6677150B2 (en) Organ preservation apparatus and methods
US8496874B2 (en) Integrated centrifugal blood pump-oxygenator, an extracorporeal life support system and a method of de-bubbling and priming an extracorporeal life support system
US20090175762A1 (en) Oxygenator unit and oxygenator apparatus
JPH02107183A (en) Cell culture apparatus
JPH02501352A (en) Cell growth reactor comprising a compartment formed by a hydrophilic diaphragm and a hydrophobic diaphragm
HUP0202317A2 (en) Method for cultivating cells, a membrane module utilization of a membrane module and reaction system for cultivation of said cells
JPS63240774A (en) bioreactor
CN113556938A (en) Aerator device
JPS6237994B2 (en)
JPH02229590A (en) Water treatment
JPS6237993B2 (en)
JPH024302B2 (en)
JPH02156957A (en) Hollow fiber membrane type oxygen enrichment device
JPS61128977A (en) Membrane type artificial lung apparatus
JPS6335763Y2 (en)
JPH0342928Y2 (en)
US20240000066A1 (en) Perfusion system
JPH0737192U (en) Hollow fiber type oxygenator
JP2020171235A (en) Cell culture apparatus and bioreactor

Legal Events

Date Code Title Description
A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20040406

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20040603

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20040907

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20040920

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20101008

Year of fee payment: 6

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20131008

Year of fee payment: 9

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees